High-throughput in-vivo CNS pharmacology screening

High-throughput in-vivo CNS pharmacology screening provides rapid, tailor-made lead validation service using selected in-vivo and ex-vivo assays.
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Charles River Discovery Research Services
 
High-throughput in-vivoCNS pharmacology screening provides rapid, tailor-made lead validation serviceusing selected in-vivo and ex-vivo assays. Locomotor activity,catalepsy test, MRI Imaging and supportive PK and receptor occupancy assaysreveal PK/PD dynamics of new molecules with administration routes fromtraditional to systemic and brain IT/ICV/IP. Endpoint sampling for tissue,plasma and CSF enables additional mechanistic characterizations.


Charles River Discovery Research Services

www.crl.com 
+35 8 17 3680 801

Related Topics

Published In

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Surface rendering of two interacting proteins (green and peach) bound together by a small molecule ligand at their interface, illustrating a protein-ligand binding event.
Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.
Stem cells are shown as clear, purple, and blue spheres against a dark blue and black background.
Human-relevant, ready-to-use stem cell models are reshaping drug discovery, toxicity testing, and personalized medicine.
Characterizing lipid nanoparticles for RNA therapeutic development
Integrated multiomics and advanced nanoparticle analytics are improving how researchers perform RNA delivery, increasing therapeutic success.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue